Adalat is the brand name for nifedipine, a calcium channel blocker prescribed primarily to lower blood pressure and prevent angina (chest pain caused by reduced blood flow to the heart). It works by relaxing the smooth muscle in artery walls, allowing blood to flow more freely and reducing the workload on the heart. While it has been on the market since the 1970s, the way doctors use it has changed dramatically over the decades, largely because its original fast-acting capsule caused serious problems that newer slow-release formulations were designed to avoid.
How Adalat Works
Nifedipine belongs to a class of drugs called dihydropyridines. These molecules block L-type voltage-operated calcium channels on the surface of smooth muscle cells lining your blood vessels.1PubMed Central. Discovery and Development of Calcium Channel Blockers Calcium flowing into those cells is what triggers them to contract and narrow the artery. Block that flow, and the muscle relaxes, the artery widens, and blood pressure drops. Compared to non-dihydropyridine calcium channel blockers like verapamil and diltiazem, dihydropyridines like nifedipine are more potent at relaxing blood vessels but have less direct effect on the heart’s own pumping strength and rhythm.2PubMed. Calcium channel blockers: differences between subclasses That distinction matters: it means nifedipine is primarily a blood-vessel drug rather than a heart-rhythm drug, which shapes both its uses and its side effects.
Treating High Blood Pressure
Lowering blood pressure is the most common reason Adalat is prescribed. Long-acting nifedipine formulations have been widely studied in this role and are supported by global evidence as effective at controlling blood pressure in patients with essential hypertension, including cases that prove resistant to other medications.3PubMed Central. Long-acting nifedipine in the management of essential hypertension: a review for cardiologists One large Canadian trial found that after 20 weeks on the long-acting formulation at 30 mg daily, patients achieved meaningful drops in both systolic and diastolic blood pressure, and the drug was well tolerated with minimal impact on overall health status.4Clinical Therapeutics. Nifedipine gastrointestinal therapeutic system (GITS) for hypertensive patients in a primary care setting: results of the Extended Release Adalat Canadian Trial (EXACT)
The emphasis on “long-acting” is not just a preference. As discussed later in this article, the original short-acting capsule caused dangerous swings in blood pressure. Modern prescribing almost always uses extended-release tablets that deliver nifedipine slowly over 24 hours, providing a steady effect without the peaks and valleys.
Angina and Coronary Artery Spasm
Adalat’s other classic use is for angina, particularly the type caused by spasm of the coronary arteries rather than fixed blockage. In Prinzmetal’s (variant) angina, a coronary artery spontaneously clamps down, choking off blood supply to heart muscle. Nifedipine directly relaxes that spasm, restoring blood flow. A study of 127 patients with coronary artery spasm found that nifedipine cut the average number of weekly angina episodes from 16 to two, and completely eliminated attacks in about two-thirds of patients.5PubMed. Nifedipine therapy for coronary-artery spasm. Experience in 127 patients Withdrawal of the drug led to recurrence, confirming it was nifedipine doing the work rather than spontaneous improvement.6PubMed. Nifedipine in the treatment of Prinzmetal’s (variant) angina
For chronic stable angina, where effort triggers chest pain because narrowed arteries cannot deliver enough oxygen during exertion, nifedipine helps through a different path. By lowering the resistance the heart pumps against, it reduces how much oxygen the heart muscle needs in the first place. Some reflex speeding of the heart rate partially offsets this benefit, but the net result is still less oxygen demand and fewer episodes of pain.7PubMed. Nifedipine in the treatment of cardiovascular disease
Why the Short-Acting Capsule Fell Out of Favor
In the 1980s and early 1990s, doctors routinely prescribed short-acting nifedipine capsules. Patients were sometimes told to bite the capsule and swallow the liquid inside during a hypertensive emergency. The problem was that this produced a sudden, steep drop in blood pressure. The body’s reflexes then kicked in hard, spiking heart rate, flushing the skin, and in some patients triggering worsening heart ischemia or stroke. A study of elderly hypertensive patients found that use of short-acting nifedipine within seven days was associated with a roughly two-and-a-half-fold increase in stroke risk, and patients newly started on it had about a fourfold increase compared to nonusers.8PubMed. Short-acting nifedipine and risk of stroke in elderly hypertensive patients
Short-acting nifedipine’s association with reflex sympathetic nervous system activation, flushing, tachycardia, worsening myocardial ischemia, and cerebrovascular ischemia is why only longer-acting formulations are now considered appropriate.9PubMed Central. Long-acting nifedipine in the management of the hypertensive patient If you encounter an older family member with leftover short-acting nifedipine capsules, that is outdated medicine and should not be used for blood pressure management. This shift from short-acting to long-acting formulations is one of the clearest examples in cardiovascular medicine of how a drug can be dangerous in one formulation and quite safe in another.
Managing Preterm Labor
One of Adalat’s most important off-label roles is in obstetrics, where it is used to slow or stop premature contractions. When a pregnant woman goes into labor too early, buying even a few extra days can make a significant difference for the baby’s lungs and brain. A systematic review covering 26 trials and over 2,000 women found that nifedipine reduced the risk of delivery within seven days of starting treatment compared to older tocolytic drugs like beta-agonists. It also lowered rates of respiratory distress syndrome, serious intestinal complications, brain hemorrhage, and admission to neonatal intensive care in the newborn.10PubMed Central. Nifedipine for the management of preterm labor: a systematic review and metaanalysis Mothers tolerated it better too, with fewer side effects and less need to stop treatment than with beta-agonists or magnesium sulfate.
A randomized trial comparing nifedipine to placebo specifically in threatened preterm labor found that about 88% of women in the nifedipine group had contractions stop after three loading doses at 90 minutes, versus about 70% in the placebo group. By 48 hours, the gap widened further.11PubMed Central. Effectiveness of nifedipine in threatened preterm labor: a randomized trial One important caveat: using nifedipine as ongoing “maintenance” tocolysis after the acute episode did not succeed at prolonging pregnancy or improving newborn outcomes compared to placebo.12PubMed Central. Nifedipine for the management of preterm labor: a systematic review and metaanalysis It works as an acute rescue, not as a long-term strategy.
Doctors do exercise caution when the mother’s cardiovascular system is already strained. In situations involving infection, twin pregnancy, pre-existing hypertension, or heart disease, nifedipine’s blood-pressure-lowering effect and fluid shifts can create risk for pulmonary edema or cardiac failure, and these complications have been reported in obstetric settings.13PubMed Central. Nifedipine compared to magnesium sulfate for treating preterm labor: A randomized clinical trial
Raynaud’s Phenomenon
If you’ve ever seen your fingers turn white and then blue in cold weather, going numb before painfully flushing red as they warm up, that’s Raynaud’s phenomenon. It happens when small arteries in the fingers (and sometimes toes) spasm in response to cold or stress. Because nifedipine relaxes arterial smooth muscle, it has long been the go-to drug for Raynaud’s. Individual trials have shown that treatment reduces attack frequency and shortens episodes, with sustained benefit over months of use.14PubMed. Nifedipine in Raynaud’s phenomenon: relationship between immediate, short term and longterm effects
The reality, however, is more modest than the early enthusiasm suggested. A Cochrane systematic review pooling seven randomized trials found that calcium channel blockers produced only a small reduction in attack frequency, translating to roughly one to two fewer episodes per week compared to placebo. As for severity of attacks, the evidence showed little meaningful effect.15PubMed Central. Calcium channel blockers for primary Raynaud’s phenomenon That’s enough benefit that many patients and doctors still consider nifedipine worth trying, especially because alternatives are limited. But it’s fair to say the drug takes the edge off Raynaud’s rather than solving it.
Preventing High-Altitude Pulmonary Edema
Here’s a use most people would never guess: nifedipine can prevent fluid from building up in the lungs during rapid ascent to high altitude. High-altitude pulmonary edema (HAPE) is a potentially fatal condition in which rising pressure in the pulmonary arteries forces fluid into the air sacs. Nifedipine lowers that pulmonary artery pressure, keeping fluid where it belongs. In a landmark study, researchers took subjects with a known history of HAPE up to about 4,500 meters. Seven of eleven who received placebo developed pulmonary edema, compared to only one of ten who received nifedipine.16PubMed. Prevention of high-altitude pulmonary edema by nifedipine
For treatment rather than prevention, nifedipine also showed promise in early studies, improving oxygenation and clearing lung edema on chest X-rays, making it a potential emergency option when descent or supplemental oxygen is not immediately possible.17PubMed. Prevention and treatment of high altitude pulmonary edema by a calcium channel blocker A later trial, though, found that when patients were hospitalized with HAPE and received standard supportive care including rest and oxygen, adding nifedipine did not speed recovery compared to placebo.18PubMed. Nifedipine for the treatment of high altitude pulmonary edema The takeaway: nifedipine’s value in altitude medicine is strongest for prevention in susceptible individuals and as a field treatment when you cannot descend. Once you are in a hospital with oxygen, it may not add much.
Chronic Anal Fissures
Anal fissures, small tears in the lining of the anal canal, can cause sharp pain and bleeding. They persist partly because spasm in the internal anal sphincter reduces blood flow to the wound, preventing healing. Nifedipine, applied topically as a gel or ointment, relaxes that sphincter muscle. A comparative study found that topical nifedipine healed about 89% of chronic fissures, compared to 58% for glyceryl trinitrate (a common alternative), with fewer side effects in the nifedipine group.19PubMed. Topical nifedipine vs. topical glyceryl trinitrate for treatment of chronic anal fissure Another trial reported a healing rate above 93% for topical nifedipine at four weeks, far exceeding the control group’s rate of about 37%.20PubMed Central. Comparative Study to Assess the Effectiveness of Topical Nifedipine and Diltiazem in the Treatment of Chronic Anal Fissure This topical use avoids most of the systemic side effects like low blood pressure and headache, since very little of the drug enters the bloodstream.
Common Side Effects
The side effects you’re most likely to encounter on oral nifedipine are headache, flushing, dizziness, and ankle swelling. The swelling deserves special attention because it is the most bothersome for many patients and the most common reason people want to stop the drug. A network meta-analysis comparing different dihydropyridines found that nifedipine ranked highest among the class for causing peripheral edema. Combining nifedipine with an angiotensin receptor blocker did not reduce this swelling, though other drug combinations fared better.21PubMed Central. Comparative peripheral edema for dihydropyridines calcium channel blockers treatment: A systematic review and network meta‐analysis The edema is not caused by heart failure or kidney problems; it results from nifedipine dilating small arteries more than small veins, which shifts fluid into surrounding tissue. Elevating the legs helps, and the swelling resolves after stopping the medication.
A less well-known side effect is gum overgrowth. Long-term nifedipine use can cause the gums to swell and grow over the teeth, sometimes severely enough to interfere with eating and appearance. In one series, 34 cardiac patients treated for a year or more developed varying degrees of gum enlargement, with five showing nodular overgrowth.22PubMed. Gingival hyperplasia caused by nifedipine. Histopathologic findings Poor oral hygiene appears to make this worse, and meticulous brushing and dental cleanings can reduce its severity.23PubMed Central. Nifedipine-induced gingival enlargement: Correlation with dose and oral hygiene Nifedipine is one of three drugs most frequently linked to gum overgrowth, alongside the anti-seizure drug phenytoin and the immune-suppressing drug cyclosporine.24PubMed Central. Nonsurgical management of nifedipine induced gingival overgrowth If you notice your gums getting puffy or tender while on Adalat, tell both your doctor and your dentist. Switching to a different blood pressure medication often allows the gums to return to normal without surgery.
The Grapefruit Problem
If your pharmacist ever warned you not to eat grapefruit while taking Adalat, this is not an overly cautious disclaimer. Grapefruit juice inhibits an enzyme system in the gut wall that normally breaks down a portion of nifedipine before it reaches your bloodstream. Block that breakdown, and substantially more of the drug gets absorbed, as though you had taken a higher dose than prescribed.25PubMed Central. Medicinal importance of grapefruit juice and its interaction with various drugs The result can be an exaggerated drop in blood pressure, flushing, headache, and dizziness. This interaction applies to whole grapefruit and grapefruit juice alike. Seville (bitter) oranges have a similar effect, but regular oranges do not.
Adalat in Children
Prescribing blood pressure medications to children involves much less certainty than in adults. The evidence base is thinner, and many drugs are used off-label based on limited pediatric studies. Calcium channel blockers, including nifedipine, are among the drug classes with the most supporting data for pediatric hypertension, alongside ACE inhibitors and angiotensin receptor blockers. Even so, significant gaps remain, particularly around long-term safety in growing children.26PubMed Central. Antihypertensive agents: a long way to safe drug prescribing in children Pediatric dosing is typically weight-based and adjusted more cautiously than in adults. If your child’s doctor prescribes nifedipine, it reflects the reality that the alternatives are not necessarily better studied and that the drug has a track record, even if it is less robust than what exists for adults.
Formulations You Might Encounter
One source of confusion for patients is that Adalat comes in several formulations, and they are not interchangeable. The original short-acting capsules (Adalat 5 mg and 10 mg) are rarely used today for the safety reasons described above. Adalat Retard (or similar slow-release names depending on the country) releases the drug over roughly 12 hours and is taken twice daily. Adalat OROS, GITS, or CC (again, naming varies by market) uses an osmotic-pump system to deliver nifedipine steadily over a full 24 hours with a single daily tablet. You may notice the empty shell of this tablet in your stool, which is normal and does not mean the medication was not absorbed.
Getting the formulation right matters. Switching between them without medical guidance can lead to blood pressure swings. If your pharmacy offers a generic substitution, check with your pharmacist that it matches the release profile of what you were taking before.